By the time you read this blog whether or not Robert F. Kennedy, Jr. will have been confirmed, or not, for the cabinet role overseeing the Department of Health and Human Services (HHS) will have
A surge of investment during the pandemic led to overstaffing and overspending with resulting widespread layoffs in the pharmaceutical and biotechnology sectors from late 2022 to late 2024. High interest rates caused funding to dwindle
As a follow up to her 2025 Commercial Analytics Trends blog, Smith Hanley Executive Recruiter, Eda Zullo, discusses pharma commercial analytics salaries across levels and specialties. VP/Senior Director/Director As Eda discussed in the December blog
What happened to 2024 Pharma R&D hiring? The slump began three months after the Federal Reserve initiated interest rate hikes in March of 2022 and persisted for over two years. The Biotech industry is very
Smith Hanley Associates’ Eda Zullo, is a Principal in the firm and the leading recruiter in the field of Commercial Analytics within pharmaceutical manufacturers as well as consulting organizations that support pharmaceutical manufacturers. Here are
Simon Wentworth of ThePhamaLetter.com asked, “How might the outcome of the forthcoming presidential election affect health policy in a country that represents both the largest market for pharmaceuticals, and the most important setting for drug
